Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2003;89:371-376; doi:10.1136/heart.89.4.371
Copyright © 2003 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2003;89:371-376
© 2003 by BMJ Publishing Group & British Cardiac Society

REVIEW

The therapeutic potential of new insights into myocardial excitation–contraction coupling

M Scoote, P A Poole-Wilson, A J Williams

Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, UK

Correspondence to:
Correspondence to:
Dr Mark Scoote, Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Dovehouse Street, London SW3 6LY, UK;
mark.scoote{at}ic.ac.uk

ABSTRACT

The physiological mechanisms that link myocyte depolarisation and contraction are referred to collectively as excitation–contraction coupling. This important process uses calcium as a second messenger to convert electrical depolarisation of the myocyte sarcolemma into the coordinated contraction of the cell’s internal myofilament apparatus. The inotropic properties of the cell are determined by the efficiency of this process and when this efficiency is lost contractile dysfunction and heart failure develop, along with a propensity for arrhythmias. Previous attempts to use positive inotropic drugs in the management of chronic heart failure have been disappointing. Such drugs have been associated with unacceptable side effects and worse morbidity and mortality outcomes, primarily through their non-specific amplification of intracellular cascade pathways that modify the cell’s inotropic state. As a result of recent advances in our understanding of how excitation–contraction coupling works in both health and disease it may be possible to design more specifically targeted drug treatment that has the potential to avoid the detrimental effect of currently available drugs while at the same time improving the inotropic properties of the cell.

Keywords: calcium channel; sarcoplasmic reticulum; cardiac arrhythmia; heart failure

Abbreviations: E-C, excitation-contraction; NCX, sarcolemmal Na+/Ca2+ exchanger; RyR2, cardiac ryanodine receptor; SERCA, sarcoplasmic reticulum Ca2+/ATPase pump; SR, sarcoplasmic reticulum


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Fung, J. W H, Chan, J. Y S, Yip, G. W K, Chan, H. C K, Chan, W. W L, Zhang, Q., Yu, C.-M. (2007). Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy. Heart 93: 432-437 [Abstract] [Full Text]  
  • Schwertz, D. W., Beck, J. M., Kowalski, J. M., Ross, J. D. (2004). Sex Differences in the Response of Rat Heart Ventricle to Calcium. Biol Res Nurs 5: 286-298 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.